(Q37680944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Diverse effects of statins on angiogenesis: new therapeutic avenues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hazem F Elewa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Payaningal R Somanath

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Susan C Fagan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

169-176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20099991%20AND%20SRC:MED&resulttype=core&format=json

Angiogenesis in cancer and other diseases

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The role of vascular endothelial growth factor in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Angiogenesis detected after embolic stroke in rat brain using magnetic resonance T2*WI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The HMG-CoA reductase pathway, statins and angioprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Cerebral ischemia and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Beyond lipid lowering: the role of statins in vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Neuroprotective properties of statins in cerebral ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Novel aspects of oxidative stress in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-1alpha upregulation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Simvastatin induces proliferation inhibition and apoptosis in C6 glioma cells via c-jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Statin therapy and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Emerging indications for statins: a pluripotent family of agents with several potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Statins have biphasic effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The role of statins in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Pathophysiological consequences of VEGF-induced vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Targets for vascular protection after acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Protective effects of erythropoietin in cardiac ischemia: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Diabetic retinopathy: current management and experimental therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

A review of Judah Folkman's remarkable achievements in biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Protein lipidation in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Beta4 integrin is involved in statin-induced endothelial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Lovastatin-induced apoptosis in human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Different anticancer effects of fluvastatin on primary hepatocellular tumors and metastases in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169

Statin use and the risk of breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.2.169